Ignite Creation Date:
2025-12-25 @ 12:00 AM
Ignite Modification Date:
2026-03-12 @ 12:38 PM
Study NCT ID:
NCT03088358
Status:
COMPLETED
Last Update Posted:
2017-03-23
First Post:
2017-02-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Efficacy of TeaRx Xa Factor Direct Inhibitor Versus Enoxaparin as a Venous Thromboembolic Events (VTE) Prevention Following Total Knee Replacement
Sponsor:
TeaRx LLC
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CV-TRX-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None